Systemic analysis of PPARγ in mouse macrophage populations reveals marked diversity in expression with critical roles in resolution of inflammation and airway immunity

Journal of Immunology

Volumn 189, Issue 5, 2012, Pages 2614-2624

  Gautier, Emmanuel L ^a,b   Chow, Andrew ^a   Spanbroek, Rainer ^c   Marcelin, Genevieve ^d   Greter, Melanie ^a   Jakubzick, Claudia ^a,f   Bogunovic, Milena ^a   Leboeuf, Marylene ^a   Van Rooijen, Nico ^e   Habenicht, Andreas J ^c   Merad, Miriam ^a   Randolph, Gwendalyn J ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; ROSIGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL CLEARANCE; CELL POPULATION; CONTROLLED STUDY; DRUG TARGETING; GENE; GENE DELETION; GENE TARGETING; HOMEOSTASIS; HOST RESISTANCE; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MONOCYTE; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA DEFICIENCY; PNEUMONIA; PPAR GAMMA GENE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY TRACT INFLAMMATION; SPLEEN MACROPHAGE; STAPHYLOCOCCAL PNEUMONIA; STEADY STATE;

ANIMALS; DISEASE RESISTANCE; GENE EXPRESSION REGULATION; INFLAMMATION; INFLAMMATION MEDIATORS; LUNG; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PPAR GAMMA; STREPTOCOCCUS PNEUMONIAE;

EID: 84865410948     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200495     Document Type: Article

References (48)

1. Glass, C. K., and S. Ogawa. 2006. Combinatorial roles of nuclear receptors in inflammation and immunity. Nat. Rev. Immunol. 6: 44-55.
2. Tontonoz, P., and B. M. Spiegelman. 2008. Fat and beyond: the diverse biology of PPARγ. Annu. Rev. Biochem. 77: 289-312.
3. Yki-Järvinen, H. 2004. Thiazolidinediones. N. Engl. J. Med. 351: 1106-1118.
4. Ricote, M., A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass. 1998. The peroxisome proliferator-activated receptor-g is a negative regulator of macrophage activation. Nature 391: 79-82.
5. Jiang, C., A. T. Ting, and B. Seed. 1998. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86.
6. Daynes, R. A., and D. C. Jones. 2002. Emerging roles of PPARs in inflammation and immunity. Nat. Rev. Immunol. 2: 748-759.
7. Su, C. G., X. Wen, S. T. Bailey, W. Jiang, S. M. Rangwala, S. A. Keilbaugh, A. Flanigan, S. Murthy, M. A. Lazar, and G. D. Wu. 1999. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. J. Clin. Invest. 104: 383-389.
8. Mukherjee, R., P. J. Davies, D. L. Crombie, E. D. Bischoff, R. M. Cesario, L. Jow, L. G. Hamann, M. F. Boehm, C. E. Mondon, A. M. Nadzan, et al. 1997. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386: 407-410.
9. Li, A. C., K. K. Brown, M. J. Silvestre, T. M. Willson, W. Palinski, and C. K. Glass. 2000. Peroxisome proliferator-activated receptor g ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 106: 523-531.
10. Babaev, V. R., P. G. Yancey, S. V. Ryzhov, V. Kon, M. D. Breyer, M. A. Magnuson, S. Fazio, and M. F. Linton. 2005. Conditional knockout of macrophage PPARγ increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 25: 1647-1653.
11. Chawla, A., W. A. Boisvert, C. H. Lee, B. A. Laffitte, Y. Barak, S. B. Joseph, D. Liao, L. Nagy, P. A. Edwards, L. K. Curtiss, et al. 2001. A PPARγ-LXRABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell 7: 161-171.
12. Shah, Y. M., K. Morimura, and F. J. Gonzalez. 2007. Expression of peroxisome proliferator-activated receptor-g in macrophage suppresses experimentally induced colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G657-G666.
13. Hevener, A. L., J. M. Olefsky, D. Reichart, M. T. Nguyen, G. Bandyopadyhay, H. Y. Leung, M. J. Watt, C. Benner, M. A. Febbraio, A. K. Nguyen, et al. 2007. Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J. Clin. Invest. 117: 1658-1669.
14. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
15. Ingersoll, M. A., R. Spanbroek, C. Lottaz, E. L. Gautier, M. Frankenberger, R. Hoffmann, R. Lang, M. Haniffa, M. Collin, F. Tacke, et al. 2010. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 115: e10-e19.
16. Heng, T. S., and M. W. Painter. 2008. The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol. 9: 1091-1094.
17. Ghosn, E. E., A. A. Cassado, G. R. Govoni, T. Fukuhara, Y. Yang, D. M. Monack, K. R. Bortoluci, S. R. Almeida, L. A. Herzenberg, and L. A. Herzenberg. 2010. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc. Natl. Acad. Sci. USA 107: 2568-2573.
18. Sung, S. S., S. M. Fu, C. E. Rose, Jr., F. Gaskin, S. T. Ju, and S. R. Beaty. 2006. A major lung CD103 (αE)-β7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 176: 2161-2172.
19. Ginhoux, F., M. Greter, M. Leboeuf, S. Nandi, P. See, S. Gokhan, M. F. Mehler, S. J. Conway, L. G. Ng, E. R. Stanley, et al. 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330: 841-845.
20. Bogunovic, M., F. Ginhoux, J. Helft, L. Shang, D. Hashimoto, M. Greter, K. Liu, C. Jakubzick, M. A. Ingersoll, M. Leboeuf, et al. 2009. Origin of the lamina propria dendritic cell network. Immunity 31: 513-525.
21. Waskow, C., K. Liu, G. Darrasse-Jèze, P. Guermonprez, F. Ginhoux, M. Merad, T. Shengelia, K. Yao, and M. Nussenzweig. 2008. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 9: 676-683.
22. Tacke, F., F. Ginhoux, C. Jakubzick, N. van Rooijen, M. Merad, and G. J. Randolph. 2006. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J. Exp. Med. 203: 583-597.
23. -/- mice during disease regression. J. Clin. Invest. 121: 2025-2036.
24. Van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174: 83-93.
25. Gautier, E. L., T. Huby, B. Ouzilleau, C. Doucet, F. Saint-Charles, G. Gremy, M. J. Chapman, and P. Lesnik. 2007. Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice. Arterioscler. Thromb. Vasc. Biol. 27: 1625-1631.
26. Qu, C., E. W. Edwards, F. Tacke, V. Angeli, J. Llodrá, G. Sanchez-Schmitz, A. Garin, N. S. Haque, W. Peters, N. van Rooijen, et al. 2004. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J. Exp. Med. 200: 1231-1241.
27. Moore, K. J., E. D. Rosen, M. L. Fitzgerald, F. Randow, L. P. Andersson, D. Altshuler, D. S. Milstone, R. M. Mortensen, B. M. Spiegelman, and M. W. Freeman. 2001. The role of PPAR-γ in macrophage differentiation and cholesterol uptake. Nat. Med. 7: 41-47.
28. Tacke, F., D. Alvarez, T. J. Kaplan, C. Jakubzick, R. Spanbroek, J. Llodra, A. Garin, J. Liu, M. Mack, N. van Rooijen, et al. 2007. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117: 185-194.
29. Bellingan, G. J., H. Caldwell, S. E. Howie, I. Dransfield, and C. Haslett. 1996. In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J. Immunol. 157: 2577-2585.
30. Arnold, L., A. Henry, F. Poron, Y. Baba-Amer, N. van Rooijen, A. Plonquet, R. K. Gherardi, and B. Chazaud. 2007. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204: 1057-1069.
31. + dendritic cells for immune T cell areas. Cell 143: 416-429.
32. Trapnell, B. C., J. A. Whitsett, and K. Nakata. 2003. Pulmonary alveolar proteinosis. N. Engl. J. Med. 349: 2527-2539.
33. Bonfield, T. L., M. J. Thomassen, C. F. Farver, S. Abraham, M. T. Koloze, X. Zhang, D. M. Mosser, and D. A. Culver. 2008. Peroxisome proliferator- activated receptor-gamma regulates the expression of alveolar macrophage macrophage colony-stimulating factor. J. Immunol. 181: 235-242.
34. Baker, A. D., A. Malur, B. P. Barna, S. Ghosh, M. S. Kavuru, A. G. Malur, and M. J. Thomassen. 2010. Targeted PPARγ deficiency in alveolar macrophages disrupts surfactant catabolism. J. Lipid Res. 51: 1325-1331.
35. Thomassen, M. J., B. P. Barna, A. G. Malur, T. L. Bonfield, C. F. Farver, A. Malur, H. Dalrymple, M. S. Kavuru, and M. Febbraio. 2007. ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis. J. Lipid Res. 48: 2762-2768.
36. Malur, A., A. D. Baker, A. J. McCoy, G. Wells, B. P. Barna, M. S. Kavuru, A. G. Malur, and M. J. Thomassen. 2011. Restoration of PPARγ reverses lipid accumulation in alveolar macrophages of GM-CSF knockout mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 300: L73-L80.
37. LeVine, A. M., J. A. Reed, K. E. Kurak, E. Cianciolo, and J. A. Whitsett. 1999. GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection. J. Clin. Invest. 103: 563-569.
38. Szanto, A., and L. Nagy. 2008. The many faces of PPARγ: anti-inflammatory by any means? Immunobiology 213: 789-803.
39. Odegaard, J. I., R. R. Ricardo-Gonzalez, M. H. Goforth, C. R. Morel, V. Subramanian, L. Mukundan, A. Red Eagle, D. Vats, F. Brombacher, A. W. Ferrante, and A. Chawla. 2007. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 447: 1116-1120.
40. Huang, J. T., J. S. Welch, M. Ricote, C. J. Binder, T. M. Willson, C. Kelly, J. L. Witztum, C. D. Funk, D. Conrad, and C. K. Glass. 1999. Interleukin- 4?dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature 400: 378-382.
41. Szanto, A., B. L. Balint, Z. S. Nagy, E. Barta, B. Dezso, A. Pap, L. Szeles, S. Poliska, M. Oros, R. M. Evans, et al. 2010. STAT6 transcription factor is a facilitator of the nuclear receptor PPARγ-regulated gene expression in macrophages and dendritic cells. Immunity 33: 699-712.
42. Serhan, C. N. 2010. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am. J. Pathol. 177: 1576-1591.
43. Fernandez-Boyanapalli, R., S. C. Frasch, D. W. Riches, R. W. Vandivier, P. M. Henson, and D. L. Bratton. 2010. PPARγ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease. Blood 116: 4512-4522.
44. Draper, D. W., J. H. Madenspacher, D. Dixon, D. H. King, A. T. Remaley, and M. B. Fessler. 2010. ATP-binding cassette transporter G1 deficiency dysregulates host defense in the lung. Am. J. Respir. Crit. Care Med. 182: 404-412.
45. -/- mice. J. Cell. Physiol. 200: 235-244.
46. Maiuri, L., A. Luciani, I. Giardino, V. Raia, V. R. Villella, M. D'Apolito, M. Pettoello-Mantovani, S. Guido, C. Ciacci, M. Cimmino, et al. 2008. Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARγ down-regulation. J. Immunol. 180: 7697-7705.
47. Harmon, G. S., D. S. Dumlao, D. T. Ng, K. E. Barrett, E. A. Dennis, H. Dong, and C. K. Glass. 2010. Pharmacological correction of a defect in PPAR-γ signaling ameliorates disease severity in Cftr-deficient mice. Nat. Med. 16: 313-318.
48. Grassmé, H., K. A. Becker, Y. Zhang, and E. Gulbins. 2010. CFTR-dependent susceptibility of the cystic fibrosis-host to Pseudomonas aeruginosa. Int. J. Med. Microbiol. 300: 578-583.